Xortx Therapeutics Inc share price logo

Xortx Therapeutics Inc Share Price

NASDAQ: XRTX

Small Cap

$0.40

-0.01

(-3.42%)

as on

Xortx Therapeutics Inc Stock Performance

as on March 21, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $0.37
    $0.42
    downward going graph

    7.50%

    Downside

    5.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.36
    $1.41
    downward going graph

    9.13%

    Downside

    252.50%

    Upside

    downward going graph

Xortx Therapeutics Inc share price movements today

Previous Close
$0.41
Open
$0.41
Volume
368.1K
Day's Low - High
$0.37 - $0.42
52 Week Low - High
$0.36 - $1.41

Xortx Therapeutics Inc Historical Returns

1 Month Return
+ 1.28 %
3 Month Return
-34.17 %
1 Year Return
-61.65 %
3 Year Return
-15.96 %
5 Year Return
0 %

Xortx Therapeutics Inc Stock Fundamentals & Key Indicators

Check Xortx Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9M

EPS (TTM)

-0.482

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.97%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-98.00%

Xortx Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xortx Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Xortx Therapeutics Inc image
Xortx Therapeutics Inc
BUY$2.9MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Xortx Therapeutics Inc Stock including INR - Dollar returns

The Xortx Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Xortx Therapeutics Inc investment value today

Current value as on today

₹48,280

Returns

₹51,720

(-51.72%)

Returns from Xortx Therapeutics Inc Stock

₹61,165 (-61.17%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Xortx Therapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Xortx Therapeutics Inc. Average target price of $14.04

Xortx Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Xortx Therapeutics Inc.

What analysts predicted

97.15%UPSIDE

Target Price

$14.04

Current Price

$0.4

Analyzed by

5 Analysts

Target

$14.04

Xortx Therapeutics Inc target price $14.04, a slight upside of 97.15% compared to current price of $0.4. According to 5 analysts rating.

Xortx Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Xortx Therapeutics Inc Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-62% versus previous 30 day period

Xortx Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-1
-1
0
0
0
0
0
0
EBITDA
-1
2
-2
0
0
0
0
0
0
0
Interest Expense
-
-
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
2
-3
0
0
0
0
0
0
0
Income Tax Expense
0
-3
1
0
-
-
-
-
-
-
Net Income
-1
2
-3
0
0
0
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Xortx Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
-
0
Operating Income
0
-1
0
-1
-2
-9
-6
-3
-4
EBITDA
0
-1
0
0
-1
-6
-2
-3
-4
Interest Expense
0
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-3
0
-1
-1
-6
-2
-4
-3
Income Tax Expense
0
0
0
0
0
-
-
-
-
Net Income
0
-2
0
0
-1
-5
-2
-4
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Xortx Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
2
-3
0
0
0
0
0
0
0
Operating Cash Flow
-1
-1
0
0
0
0
0
0
0
Investing Cash Flow
0
0
0
0
-
0
0
0
0
Financing Cash Flow
0
1
0
0
1
0
0
0
0
Change in Cash
-1
0
0
0
0
0
0
0
0

Xortx Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-3
0
-1
-1
-6
-2
-3
-3
Operating Cash Flow
0
-1
0
0
-4
-8
-6
-3
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
0
0
19
4
0
2
1
Change in Cash
0
0
0
0
14
-3
-6
0
-2

Global Institutional Holdings in Xortx Therapeutics Inc

Funds
Holdings
Armistice Capital, LLC
0%
Hartland & Co
0%
XTX Topco Ltd
0.2%
Hartland & Co
0%
Advisor Group Holdings, Inc.
0%
See all

Xortx Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 29 October

    Wed, 04:31 PM

    -

    XORTX Therapeutics closes US$1.1 million registered direct offering for working capital and corporate purposes.

Insights on Xortx Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 73.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Xortx Therapeutics Inc has experienced a drawdown of -22.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 20.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, XRTX stock has moved down by -28.3%

About Xortx Therapeutics Inc

xortx therapeutics inc., a bio-pharmaceutical company, focuses on the development and commercialization of therapies to treat progressive kidney diseases worldwide. it has two lead programs, including treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. the company focuses on developing therapies for health consequences that includes pre-diabetes, diabetes, and cardiovascular disease. in addition, it develops uric acid lowering agents to treat diabetic nephropathy, hypertension, insulin resistance, metabolic syndrome, and diabetes; and xanthine oxidase inhibitors. the company has a strategic alliance with teijin pharma limited to develop tmx-049, a xanthine oxidoreductase; and a partnership with the icahn school of medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with covid-19. xortx therapeutics inc. is headquartered in calgary, canada.
OrganisationXortx Therapeutics Inc
Headquarters3710 - 33rd Street NW, Calgary, AB, Canada, T2L 2M1
CEODr. Allen Warren Davidoff Ph.D.
E-voting on sharesClick here to vote

Key Management of Xortx Therapeutics Inc

Name

Title

Dr. Allen Warren Davidoff Ph.D.

Founder, CEO, President & Director

Dr. Michael Scott Bumby D.V.M., M.B.A.

Chief Financial Officer

Dr. Stephen Haworth M.D., MRCP

Chief Medical Officer

Dr. Stacy Evans M.B.A., M.D.

Chief Business Officer

Nick Rigopoulos

Director of Communications

Dr. David Sans M.B.A., Ph.D.

Director of Corporate Development

Dr. David MacDonald Ph.D.

Consultant of Clinical Operations

Ms. Charlotte May

Corporate Secretary

FAQs

What is Xortx Therapeutics Inc share price today?

Xortx Therapeutics Inc share price today is $0.4 as on at the close of the market. Xortx Therapeutics Inc share today touched a day high of $0.42 and a low of $0.37.

What is the 52 week high and 52 week low for Xortx Therapeutics Inc share?

Xortx Therapeutics Inc share touched a 52 week high of $1.41 on and a 52 week low of $0.36 on . Xortx Therapeutics Inc stock price today i.e. is closed at $0.4,which is 71.63% down from its 52 week high and 10.04% up from its 52 week low.

What is Xortx Therapeutics Inc's market capitalisation today?

Xortx Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Xortx Therapeutics Inc Stock (XRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xortx Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xortx Therapeutics Inc Shares that will get you 3.7500 shares as per Xortx Therapeutics Inc share price of $0.4 per share as on March 21, 2026 at 1:27 am IST.

What is the minimum amount required to buy Xortx Therapeutics Inc Stock (XRTX) from India?

Indian investors can start investing in Xortx Therapeutics Inc (XRTX) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Xortx Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xortx Therapeutics Inc share’s latest price of $0.4 as on March 21, 2026 at 1:27 am IST, you will get 25.0000 shares of Xortx Therapeutics Inc. Learn more about fractional shares .